Power Law company profile

Aragon Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 2009 Unicorn

Asthma Research Studies Now Enrolling

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

4 investors on Aragon Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

The Column Group

OrbiMed

Series B+ 2 investors entered at this stage

Aisling Capital

venBio Partners

Global footprint

Where Aragon Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Patent intelligence

$118M patent portfolio · 42 active families

Estimated portfolio value

$118M

comparable to top peer Deciphera Pharmaceuticals ($133M)

42 active patent families

Where Aragon Pharmaceuticals innovates Cancer researchOncologyCastrationAndrogen Receptor GeneCastration Resistance

Where Aragon Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Aragon Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Aragon Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Aragon Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aragon Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles